Article information
Abstract
Infections caused by Staphylococcus aureus are a major problem in hospitals. The multidrug resistance and the nasal carriage of S. aureus play a key role in the epidemic of these infections. In this prospective study, 160 S. aureus strains were isolated from pathological samples of patients (79 cases) and nasal swabs (81) of cases and controls from January to July 2007. The susceptibility to 16 antibiotics, including cefoxitin, was determined by the agar diffusion method, and methicillin resistance was confirmed by amplifying the mecA gene by polymerase chain reaction (PCR). The prevalence of methicilin-resistant S. aureus (MRSA) was high in the burns (57.7%) and dermatology (39.4%) wards, and the MRSA strains isolated were extremely multi-resistant, but all of them were still susceptible to vancomycin. The rate of S. aureus nasal carriage was high in both cases and controls, in state, MRSA nasal carriage was more common among people infected with S. aureus.
Keywords:
Drug resistance
Methicillin-resistant Staphylococcus aureus
Nasal cavity
Staphylococcal infections
Full text is only available in PDF
References
[1.]
P.A. Maple, J.M. Hamilton-Miller, W. Brumfitt.
World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.
Lancet, 333 (1989), pp. 537-540
[2.]
J. Kluytmans, A. van Belkum, H. Verbrugh.
Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks.
Clin Microbiol Rev, 10 (1997), pp. 505-520
[3.]
Sambrook, J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. 1989.
[4.]
K. Murakami, W. Minamide, K. Wada, E. Nakamura, H. Teraoka, S. Watanabe.
Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction.
J Clin Microbiol, 29 (1991), pp. 2240-2244
[5.]
C. Kesah, S. Ben Redjeb, et al.
Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta.
Clin Microbiol Infect, 9 (2003), pp. 153-156
[6.]
H. Belabbès, N. Elmdaghri, K. Hachimi, L. Marih, K. Zerouali, M. Benbachir.
Antibiotic resistance of Staphylococcus aureus isolated from community and nosocomial infections in Casablanca.
Med Mal Infect, 39 (2001), pp. 25-28
[7.]
M.A. Borg, M. de Kraker, E. Scicluna, et al.
Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in invasive isolates from southern and eastern Mediterranean countries.
J Antimicrob Chemother, 60 (2007), pp. 1310-1315
[8.]
L. Thabet, A. Messadi, M. Mbarek, A. Turki, B. Meddeb, S. Ben Redjeb.
Surveillance of multidrug resistant bacteria in a Tunisian hospital.
Tunis Med, 86 (2008), pp. 992-995
[9.]
A.A. Zorgani, A. Shahen, M. Zaidi, M. Franka.
A profile and spectrum of four cases of methicillin-resistant Staphylococcus aureus in a burns intensive care unit.
Ann Burns Fire Disasters, 19 (2006), pp. 5-10
[10.]
H. Rode, D. Hanslo, P.M. de Wet, A.J. Millar, S. Cywes.
Efficacy of mupirocin in methicillin-resistant Staphylococcus aureus burn wound infection.
Antimicrob Agents Chemother, 33 (1989), pp. 1358-1361
[11.]
T. Ito, K. Hiramatsu.
Acquisition of methicillin resistance and progression of multiantibiotic resistance in methicillin-resistant Staphylococcus aureus.
Yonsei Med J, 39 (1998), pp. 526-533
[12.]
M.A. Domínguez, J. Liñares, R. Martín.
Molecular mechanisms of methicillin resistance in Staphylococcus aureus.
Microbiologia, 13 (1997), pp. 301-308
[13.]
M. Bassetti, E. Nicco, M. Mikulska.
Why is community-associated MRSA spreading across the world and how will it change clinical practice?.
Int J Antimicrob Agents, 34 (2009), pp. 15-19
[14.]
A.O. Shittu, J. Lin.
Antimicrobial susceptibility patterns and characterization of clinical isolates of Staphylococcus aureus in KwaZulu-Natal province South Africa.
BMC Infect Dis, 6 (2006), pp. 125
[15.]
B. Shrestha, B.M. Pokhrel, T.M. Mohapatra.
Phenotypic characterization of nosocomial isolates of Staphylococcus aureus with reference to MRSA.
J Infect Dev Ctries, 3 (2009), pp. 554-560
[16.]
P. Sacha, P. Wieczorek, P. Jakoniuk.
Susceptibility of Staphylococcus aureus to new macrolide antibiotics.
Przegl Lek, 65 (2008), pp. 225-228
[17.]
S. Elhamzaoui, A. Benouda, F. Allal, R. Abouqual, R. Elouennass.
Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat Morocco.
Med Mal Infect, 39 (2009), pp. 891-895
[18.]
P.S. Loomba, J. Taneja, B. Mishra.
Methicillin and vancomycin resistant S. aureus in hospitalized patients.
J Glob Infect Dis, 2 (2010), pp. 275-283
[19.]
M. Popovic, D. Steinort, S. Pillai, C. Joukhadar.
Fosfomycin: an old, new friend?.
Eur J Clin Microbiol Infect Dis, 29 (2010), pp. 127-142
[20.]
F.D. Lowy.
Antimicrobial resistance: the example of Staphylococcus aureus.
J Clin Invest, 111 (2003), pp. 1265-1273
[21.]
M. Shah, M. Mohanraj.
High levels of fusidic acid-resistant Staphylococcus aureus in dermatology patients.
Br J Dermatol, 148 (2003), pp. 1018-1020
[22.]
R.E. Williams.
Healthy carriage of Staphylococcus aureus: its prevalence and importance.
Bacteriol Rev, 27 (1963), pp. 56-71
[23.]
H.F. Wertheim, M.C. Vos, A. Ott, et al.
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers.
Lancet, 364 (2004), pp. 703-705
[24.]
N. Safdar, E.A. Bradley.
The risk of infection after nasal colonization with Staphylococcus aureus.
Am J Med, 121 (2008), pp. 310-315
Copyright © 2012. Elsevier Editora Ltda.. All rights reserved
